about
Gemcitabine, ifosfamide and vinorelbine in advanced non-small cell lung cancer: a phase II study.Phase I study of liposomal doxorubicin and oxaliplatin as salvage chemotherapy in advanced ovarian cancer.High-dose carboplatin, cyclophosphamide, etoposide with hematological growth factors, without stem cell support in patients with advanced cancer.Chemoimmunotherapy in the treatment of metastatic gastric cancer.Multicenter phase II study of chemo-immunotherapy in the treatment of metastatic renal cell carcinoma.Multicenter phase II study of chemoimmunotherapy in the treatment of metastatic melanoma.Minimal residual disease in metastatic breast cancer: treatment with IFN-beta, retinoids, and tamoxifen.Primitive sarcoma of the breast: new insight on the proper surgical management.High-risk early breast cancer in patients under 40 years of age: Improved clinical outcome with total estrogen blockade and tailored chemotherapy.Triple-negative breast cancer: multipronged approach, single-arm pilot phase II study.Multicentre phase II study of bifractionated CPT-11 with bimonthly leucovorin and 5-fluorouracil in patients with metastatic colorectal cancer pretreated with FOLFOX.Vascular endothelial growth factor expression and T-regulatory cells in premenopausal breast cancerAnthracycline-based induction chemotherapy followed by concurrent cyclophosphamide, methotrexate and 5-fluorouracil and radiation therapy in surgically resected axillary node-positive breast cancer.Multicenter phase 2 study of interleukin-2 and 13-cis retinoic acid as maintenance therapy in advanced non-small-cell lung cancer.Interleukin-2 and 13-cis retinoic acid in the treatment of minimal residual disease: a phase II study.Randomized trial of sequential administration of G-CSF and GM-CSF vs. G-CSF alone following peripheral blood progenitor cell autograft in solid tumors.Phase I-II study of dose intensified chemotherapy with filgrastim and thymopentin in patients with advanced cancer.[Role of polychemoembolization in the treatment of primary and secondary tumors of the liver].LH-RH analogues in the treatment of young women with early breast cancer: long-term follow-up of a phase II study.Maintenance immunotherapy in recurrent ovarian cancer: long term follow-up of a phase II study.Goserelin as ovarian protection in the adjuvant treatment of premenopausal breast cancer: a phase II pilot study.5-fluorouracil-carboplatin continuous infusion as salvage chemotherapy in advanced cancer.Multicenter phase II study of CPT-11 fractionated over two days with bimonthly leucovorin and 5-fluorouracil in patients with metastatic colorectal cancer.Chemoradioimmunotherapy in locally advanced pancreatic and biliary tree adenocarcinoma: a multicenter phase II study.Gonadotropin-releasing hormone analogues added to adjuvant chemotherapy protect ovarian function and improve clinical outcomes in young women with early breast carcinoma.A new sphincter-splitting operation for surgical access to low-lying tumors of the rectum.Splenic salvage using an absorbable mesh: feasibility, reliability and safety[Cytological studies in the diagnosis of pulmonary carcinoma][Prevention of hepatic metastases in radically operated colonic cancers]Closed peritoneal lavage in the diagnosis of non traumatic acute abdomenVentral incisional hernias: incidence, date of recurrence, localization and risk factorsSequential chemotherapy, beta interferon, retinoids and tamoxifen in the treatment of metastatic breast cancer. A pilot studyInterferon-beta, retinoids, and tamoxifen in the treatment of metastatic breast cancer: a phase II study[5-fluorouracil, cisplatin and retinol palmitate in the management of advanced cancer of the oral cavity. Phase II study]Lung metastases of renal cell carcinoma: results of surgical resectionCarboplatin, vindesine, 5-fluorouracil-leucovorin and 13-cis retinoic acid in the treatment of advanced non-small cell lung cancer. A phase II studyCombined chemotherapy and differentiation therapy in the treatment of advanced non-small-cell lung cancerCarboplatin, ifosfamide, and vinorelbine in the treatment of advanced non-small-cell lung cancer: a phase II studyBeta-interferon, retinoids and tamoxifen combination in advanced breast cancerA multicenter phase II study of pegylated liposomal doxorubicin and oxaliplatin in recurrent ovarian cancer
P50
Q33343636-702EE555-2AE8-4277-B109-AC39D349384EQ33356847-51D8CE95-24F8-410A-8361-748A0413C6A8Q33358006-0ABC84C8-9B79-4F0F-B3DC-AC500E713A7FQ33374828-0101EA44-8427-49A5-BD8E-14B00C73256EQ33375009-5B4DE757-7DA0-454A-AB69-98DDE8CA35C3Q33378163-4679BFC5-0C3B-40EE-A48B-F3D7E5C1E0B8Q33501711-C27B32AB-A9B8-4AF1-B0E4-38A7E09A0CBAQ35899940-89B4FC80-D0FC-41A7-B2FE-F0D5F0E1665FQ36244136-AB104031-174D-4AE4-A9FE-27779E86B27BQ36530636-3BBB9324-3320-4D00-8F16-F62969245020Q36695803-AAC3C103-DFE9-4044-9F02-98C8D50BE562Q36774786-35A24E17-4235-4A46-84AA-A8D92D450C29Q37722185-4A708F3F-88EC-4743-881C-C0E7C324EEFEQ40490603-A8ED09A8-68AB-4138-83E1-94F83ACBCFAAQ40582214-52C22CB4-96A6-4F51-A78A-F478AEC7AA9AQ40625051-383B1F8C-2479-4843-AFDA-948CE6483CF8Q40650864-6BD3EACD-9C50-45F9-A6B5-DD179011D5E7Q40688954-FD1E35F4-709F-4FCC-9113-3C7D77D66A3AQ41603322-7E3F549A-44BE-449A-8F3D-85D1394EE730Q43251199-420AF9C5-8EE7-4CAA-BC74-943B08D41EB1Q43976445-AD16A69E-2427-472C-A5C6-8E0FC381419AQ43979105-C8B8F7B1-907F-4624-874B-0B8E052C87C6Q44554100-7BA6EC2E-BF50-44B3-B0C1-BBB2B5F19FE7Q45966694-FC4D3B10-49B6-4232-A11B-7EF729CFC8E8Q46875708-C28E87AA-DA9F-4859-B02E-D1BF882F3B7FQ51776442-60F76A04-78F2-4932-B4F1-8C647CA3E0ACQ68110506-BB92E775-4238-4CE6-B953-F9E1078B6626Q68712900-45766753-9663-40DE-B38D-431DAD62988AQ70218988-9DABA8C5-6BE5-4FB4-BE7E-C8B4D7D26C0EQ70247480-C5E12D2B-E806-4A6C-B761-1A76327123E7Q70249678-3D80BE7A-E1FA-4B8B-9062-C6970642863AQ70836394-646E5BC8-5059-4B57-99B9-6D3E2BD0B4FFQ71728157-9F4EBB2F-152D-4D88-9F00-EBD768D1363CQ72852501-6BA07F98-F949-4153-BD5E-F45DF9F12F8BQ73068053-58C0B5B0-AFEB-4D89-8798-37F5E662463EQ73289920-EE878898-CABC-40A3-808C-1001338D6583Q74034088-4F4209CB-6A12-4A06-AC2F-F399D8C7AA73Q74455165-A08C75FD-C93A-48AC-BB29-A3DA6ABED3F4Q77644287-5119F9B5-8809-4CAC-82B1-E1A9547098D6Q80270243-BA992AA2-C31F-4965-982E-0DD126A671B6
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
研究者
@zh
name
Silvio Rea
@ast
Silvio Rea
@en
Silvio Rea
@es
Silvio Rea
@nl
type
label
Silvio Rea
@ast
Silvio Rea
@en
Silvio Rea
@es
Silvio Rea
@nl
prefLabel
Silvio Rea
@ast
Silvio Rea
@en
Silvio Rea
@es
Silvio Rea
@nl
P106
P1153
7005192770
P21
P31
P496
0000-0002-1439-2768